In the two glioma surgical specimen groups, the expression levels of BMPER, CXCL10 and HOXA9 in the surgical specimens that could form xenografts were significantly higher than those in the surgical specimens that could not form xenografts. This evidence concerns the gene BMPER and central nervous system cancer.